Grimwood S, Wilde G J, Foster A C
Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, England.
J Neurochem. 1993 May;60(5):1729-38. doi: 10.1111/j.1471-4159.1993.tb13397.x.
The N-methyl-D-aspartate (NMDA) receptor possesses two distinct amino acid recognition sites, one for glutamate and one for glycine, which appear to be allosterically linked. Using rat cortex/hippocampus P2 membranes we have investigated the effect of glutamate recognition site ligands on [3H]glycine (agonist) and (+-)-4-trans-2-carboxy-5,7-dichloro-4- [3H]phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline ([3H]L-689,560; antagonist) binding to the glycine site and the effect of glycine recognition site ligands on L-[3H]glutamate (agonist), DL-3-(2-carboxypiperazin-4-yl)-[3H]propyl-1-phosphonate ([3H]CPP; "C-7" antagonist), and cis-4-phosphonomethyl-2-[3H]piperidine carboxylate ([3H]CGS-19755; "C-5" antagonist) binding to the glutamate site. "C-7" glutamate site antagonists partially inhibited [3H]L-689,560 binding but had no effect on [3H]glycine binding, whereas "C-5" antagonists partially inhibited the binding of both radioligands. Glycine, D-serine, and D-cycloserine partially inhibited [3H]CGS-19755 binding but had little effect on L-[3H]glutamate or [3H]CPP binding, whereas the partial agonists (+)-3-amino-1-hydroxypyrrolid-2-one [(+)-HA-966], 3R-(+)cis-4-methyl-HA-966 (L-687,414), and 1-amino-1-carboxycyclobutane all enhanced [3H]CPP binding but had no effect on [3H]CGS-19755 binding, and (+)-HA-966 and L-687,414 inhibited L-[3H]glutamate binding. The association and dissociation rates of [3H]L-689,560 binding were decreased by CPP and D-2-amino-5-phosphonopentanoic acid ("C-5"). Saturation analysis of [3H]L-689,560 binding sites. These results indicate that complex interactions occur between the glutamate and glycine recognition sites on the NMDA receptor. In addition, mechanisms other than allosterism may underlie some effects, and the possibility of a steric interaction between CPP and [3H]L-689,560 is discussed.
N-甲基-D-天冬氨酸(NMDA)受体具有两个不同的氨基酸识别位点,一个用于谷氨酸,另一个用于甘氨酸,这两个位点似乎存在变构联系。我们使用大鼠皮层/海马P2膜,研究了谷氨酸识别位点配体对[3H]甘氨酸(激动剂)和(±)-4-反式-2-羧基-5,7-二氯-4-[3H]苯基氨基羰基氨基-1,2,3,4-四氢喹啉([3H]L-689,560;拮抗剂)与甘氨酸位点结合的影响,以及甘氨酸识别位点配体对L-[3H]谷氨酸(激动剂)、DL-3-(2-羧基哌嗪-4-基)-[3H]丙基-1-膦酸酯([3H]CPP;“C-7”拮抗剂)和顺式-4-膦酰甲基-2-[3H]哌啶羧酸盐([3H]CGS-19755;“C-5”拮抗剂)与谷氨酸位点结合的影响。“C-7”谷氨酸位点拮抗剂部分抑制[3H]L-689,560的结合,但对[3H]甘氨酸结合无影响,而“C-5”拮抗剂则部分抑制两种放射性配体的结合。甘氨酸、D-丝氨酸和D-环丝氨酸部分抑制[3H]CGS-19755的结合,但对L-[3H]谷氨酸或[3H]CPP的结合影响很小,而部分激动剂(+)-3-氨基-1-羟基吡咯烷-2-酮[(+)-HA-966]、3R-(+)顺式-4-甲基-HA-966(L-687,414)和1-氨基-1-羧基环丁烷均增强[3H]CPP的结合,但对[3H]CGS-19755的结合无影响,且(+)-HA-966和L-687,414抑制L-[3H]谷氨酸的结合。CPP和D-2-氨基-5-膦酰戊酸(“C-5”)降低了[3H]L-689,560结合的缔合和解离速率。[3H]L-689,560结合位点的饱和分析。这些结果表明,NMDA受体上的谷氨酸和甘氨酸识别位点之间发生了复杂的相互作用。此外,变构以外的机制可能是某些效应的基础,并且讨论了CPP与[3H]L-689,560之间发生空间相互作用的可能性。